Beauty Health (NASDAQ:SKIN) Given New $22.00 Price Target at JPMorgan Chase & Co.

Beauty Health (NASDAQ:SKINGet Rating) had its price target lifted by JPMorgan Chase & Co. from $18.00 to $22.00 in a research note published on Friday, The Fly reports.

SKIN has been the subject of a number of other research reports. Canaccord Genuity Group decreased their price target on shares of Beauty Health from $22.00 to $20.00 and set a buy rating for the company in a research report on Thursday, June 30th. The Goldman Sachs Group decreased their price target on shares of Beauty Health from $25.00 to $22.00 and set a buy rating for the company in a research report on Tuesday, August 16th. Canaccord Genuity Group decreased their price target on shares of Beauty Health from $22.00 to $20.00 in a research report on Thursday, June 30th. DA Davidson raised their price objective on Beauty Health from $25.00 to $30.00 and gave the stock a buy rating in a research note on Friday. Finally, Piper Sandler raised their price objective on Beauty Health from $20.00 to $23.00 and gave the stock an overweight rating in a research note on Friday. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $25.00.

Beauty Health Stock Down 4.7 %

SKIN stock opened at $11.98 on Friday. Beauty Health has a twelve month low of $9.94 and a twelve month high of $30.17. The company has a current ratio of 11.44, a quick ratio of 10.59 and a debt-to-equity ratio of 2.08. The company has a market capitalization of $1.81 billion, a P/E ratio of -6.21 and a beta of 1.49. The firm has a 50 day simple moving average of $12.76 and a 200-day simple moving average of $13.88.

Institutional Investors Weigh In On Beauty Health

A number of hedge funds have recently added to or reduced their stakes in the stock. Arizona State Retirement System lifted its stake in Beauty Health by 12.6% in the first quarter. Arizona State Retirement System now owns 26,292 shares of the company’s stock valued at $444,000 after buying an additional 2,951 shares during the last quarter. Teacher Retirement System of Texas lifted its stake in Beauty Health by 18.8% in the first quarter. Teacher Retirement System of Texas now owns 20,118 shares of the company’s stock valued at $340,000 after buying an additional 3,190 shares during the last quarter. American International Group Inc. lifted its stake in Beauty Health by 7.8% in the second quarter. American International Group Inc. now owns 46,688 shares of the company’s stock valued at $600,000 after buying an additional 3,385 shares during the last quarter. Skylands Capital LLC lifted its stake in Beauty Health by 12.4% in the second quarter. Skylands Capital LLC now owns 31,350 shares of the company’s stock valued at $403,000 after buying an additional 3,450 shares during the last quarter. Finally, New York State Common Retirement Fund lifted its stake in Beauty Health by 5.0% in the first quarter. New York State Common Retirement Fund now owns 106,513 shares of the company’s stock valued at $1,798,000 after buying an additional 5,033 shares during the last quarter. 78.59% of the stock is currently owned by institutional investors.

Beauty Health Company Profile

(Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.

Featured Stories

The Fly logo

Analyst Recommendations for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.